167 reports of this reaction
3.2% of all CEVIMELINE HYDROCHLORIDE reports
#2 most reported adverse reaction
HEADACHE is the #2 most commonly reported adverse reaction for CEVIMELINE HYDROCHLORIDE, manufactured by Aurobindo Pharma Limited. There are 167 FDA adverse event reports linking CEVIMELINE HYDROCHLORIDE to HEADACHE. This represents approximately 3.2% of all 5,260 adverse event reports for this drug.
Patients taking CEVIMELINE HYDROCHLORIDE who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is moderately reported among CEVIMELINE HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to headache, the following adverse reactions have been reported for CEVIMELINE HYDROCHLORIDE:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 167 FDA reports for CEVIMELINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 3.2% of all adverse event reports for CEVIMELINE HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience headache while taking CEVIMELINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.